Molecular and Cellular Biology, April 1999, p. 3073-3085, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
INSERM U459, Faculté de Médecine Henri Warembourg, 59045 Lille Cedex, France
Received 9 October 1998/Returned for modification 10 November 1998/Accepted 12 January 1999
Transcriptional activation by retinoids is mediated through two
families of nuclear receptors, all-trans-retinoic acid
(RARs) and 9-cis retinoic acid receptors (RXRs).
Conformationally restricted retinoids are used to achieve selective
activation of RAR isotype
,
or
, which reduces side effects
in therapeutical applications. Synthetic retinoids mimic some of
all-trans retinoic acid biological effects in vivo but
interact differently with the ligand binding domain of RAR
and
induce distinct structural transitions of the receptor. In this report,
we demonstrate that RAR-selective ligands have distinct quantitative
activation properties which are reflected by their abilities to promote
interaction of DNA-bound human RXR
(hRXR
)-hRAR
heterodimers
with the nuclear receptor coactivator (NCoA) SRC-1 in vitro. The
hormone response element core motifs spacing defined the relative
affinity of liganded heterodimers for two NCoAs, SRC-1 and RIP140.
hRXR
activating function 2 was critical to confer hRAR
full responsiveness but not differential sensitivity of hRAR
to
natural or synthetic retinoids. We also provide evidence showing
that lysines located in helices 3 and 4, which define part of hRAR
NCoA binding surface, contribute differently to (i) the transcriptional
activity and (ii) the interaction of RXR-RAR heterodimers with SRC-1,
when challenged by either natural or RAR-selective retinoids.
Thus, ligand structure, DNA, and RXR exert allosteric regulations on
hRAR
conformation organized as a DNA-bound heterodimer. We
suggest that the use of physically distinct NCoA binding interfaces may
be important in controlling specific genes by conformationally
restricted ligands.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|